Clinical Trial Update: Switching to Duloxetine From Other Antidepressants [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated outcomes of switching patients with Major Depressive Disorder from other antidepressants to duloxetine, sponsored by Eli Lilly and Com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED